Some Science of Pro 140 (PA14) (Leronlimab) ccr5 cydy

New Post Public Reply Private Reply Replies (1) Message Board
trding
10,242
Some Science of Pro 140 (PA14) (Leronlimab) ccr5 cydy cytodyn tnbc nash hiv

Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5
William C. Olson, Gwénaël E. E. Rabut, Kirsten A. Nagashima, Diep N. H. Tran, Deborah J. Anselma, Simon P. Monard, Jeremy P. Segal, Daniah A. D. Thompson, Francis Kajumo, Yong Guo, John P. Moore, Paul J. Maddon, Tatjana Dragic
Journal of Virology May 1999, 73 (5) 4145-4155;
https://jvi.asm.org/content/73/5/4145.short


Potent, Broad-Spectrum Inhibition of Human Immunodeficiency Virus Type 1 by the CCR5 Monoclonal Antibody PRO 140
Alexandra Trkola, Thomas J. Ketas, Kirsten A. Nagashima, Lu Zhao, Tonie Cilliers, Lynn Morris, John P. Moore, Paul J. Maddon, William C. Olson
Journal of Virology Jan 2001, 75 (2) 579-588
https://jvi.asm.org/content/75/2/579.short

HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use
Alexandra Trkola, Shawn E. Kuhmann, Julie M. Strizki, Elizabeth Maxwell, Tom Ketas, Tom Morgan, Pavel Pugach, Serena Xu, Lisa Wojcik, Jayaram Tagat, Anandan Palani, Sherry Shapiro, John W. Clader, Stuart McCombie, Gregory R. Reyes, Bahige M. Baroudy, and John P. Moore
PNAS January 8, 2002 99 (1) 395-400
https://www.pnas.org/content/99/1/395.short


HIV entry inhibitors: mechanisms of action and resistance pathways
Verónica Briz, Eva Poveda, Vincent Soriano
Journal of Antimicrobial Chemotherapy, Volume 57, Issue 4, April 2006, Pages 619–627,
https://academic.oup.com/jac/article/57/4/619/669426


Susceptibility of pediatric HIV-1 isolates to recombinant CD4-IgG2 (PRO 542) and humanized mAb to the chemokine receptor CCR5 (PRO 140)
Shearer, William T; DeVille, Jaime G; Samson, Pearl M; Moye, John H; Fletcher, Courtney V
Journal of Allergy and Clinical Immunology; St. Louis Vol. 118, Iss. 2, (Aug 2006): 518-521
https://search.proquest.com/openview/35e40dec...806d0113/1

An anti-CCR5 monoclonal antibody and small molecule CCR5 antagonists synergize by inhibiting different stages of human immunodeficiency virus type 1 entry
Diana Safariana Xavier Carneca,Fotini Tsamisa, Francis Kajumoab, Tatjana Dragica
Virology
Volume 352, Issue 2, 1 September 2006, Pages 477-484
https://www.sciencedirect.com/science/article...2206003369

Potent Antiviral Synergy between Monoclonal Antibody and Small-Molecule CCR5 Inhibitors of Human Immunodeficiency Virus Type 1
Jose D. Murga, Michael Franti, Daniel C. Pevear, Paul J. Maddon, William C. Olson
Antimicrobial Agents and Chemotherapy Sep 2006, 50 (10) 3289-3296;
https://aac.asm.org/content/50/10/3289.short


HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry
Pavel Pugach, Andre Marozsan, Thomas Ketas, Elissa Landes, John Moore, Shawn Kuhmann
Virology Volume 361, Issue 1, 25 April 2007, Pages 212-228
https://www.sciencedirect.com/science/article...2206008245

Antiviral Activity of Single-Dose PRO 140, a CCR5 Monoclonal Antibody, in HIV-Infected Adults
Jeffrey M. Jacobson, Michael S. Saag, Melanie A. Thompson, Margaret A. Fischl, Ralph Liporace, Richard C. Reichman, Robert R. Redfield, Carl J. Fichtenbaum, Barry S. Zingman, Mahesh C. Patel, Jose D. Murga, Suzanne M. Pemrick, Paul D'Ambrosio, Marti Michael, Hans Kroger, Hieu Ly, Yakov Rotshteyn, Robert Buice, Stephen A. Morris, Joseph J. Stavola, Paul J. Maddon, Alton B. Kremer, William C. Olson
The Journal of Infectious Diseases, Volume 198, Issue 9, 1 November 2008, Pages 1345–1352
https://academic.oup.com/jid/article/198/9/1345/834086

Single-Dose PRO 140 Has Lasting Effects
Tim Horn, 21 Sept 2007. POZ.com
https://www.poz.com/article/Single-Dose-PRO-1...13079-7759


ICAAC: Phase 1 study provides `proof of concept` for PRO 140, a monoclonal CCR5 antibody
Derek Thaczuk, 21 September 2007
https://www.aidsmap.com/news/sep-2007/icaac-p...5-antibody


New approaches in the treatment of HIV/AIDS – focus on maraviroc and other CCR5 antagonists
Hans P Schlecht, Sarah Schellhorn, Bruce J Dezube, and Jeffrey M Jacobson
Ther Clin Risk Manag. 2008 Apr; 4(2): 473–485.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2504054/


CCR5 Monoclonal Antibodies for HIV-1 Therapy
William C. Olson and Jeffrey M. Jacobson
Curr Opin HIV AIDS. 2009 Mar; 4(2): 104–111.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2760828/

Phase 2a Study of the CCR5 Monoclonal Antibody PRO 140 Administered Intravenously to HIV-Infected Adults
Jeffrey M. Jacobson, Jacob P. Lalezari, Melanie A. Thompson, Carl J. Fichtenbaum, Michael S. Saag, Barry S. Zingman, Paul D'Ambrosio, Nancy Stambler, Yakov Rotshteyn, Andre J. Marozsan, Paul J. Maddon, Stephen A. Morris, William C. Olson
Antimicrobial Agents and Chemotherapy Sep 2010, 54 (10) 4137-4142
https://aac.asm.org/content/54/10/4137.short


Anti-HIV-1 Activity of Weekly or Biweekly Treatment with Subcutaneous PRO 140, a CCR5 Monoclonal Antibody
Jeffrey M. Jacobson, Melanie A. Thompson, Jacob P. Lalezari, Michael S. Saag, Paul Zingman, Barry S. D'Ambrosio, Nancy Stambler, Yakov Rotshteyn, Andre J. Marozsan, Paul J. Maddon, Stephen A. Morris, William C. Olson
The Journal of Infectious Diseases, Volume 201, Issue 10, 15 May 2010, Pages 1481–1487
https://academic.oup.com/jid/article/201/10/1481/992206

PRO 140 - A Novel CCR5 Co-Receptor Inhibitor
Khatib, Nadia; Das, Satyajit
Recent Patents on Anti-Infective Drug Discovery, Volume 5, Number 1, 2010, pp. 18-22(5)
https://www.ingentaconnect.com/content/ben/pr...1/art00003

The Monoclonal CCR5 Antibody PRO-140: The Promise of Once-Weekly HIV Therapy
Jacobson JM, Thompson MA, Lalezari JP, et al.: Anti–HIV-1 activity of weekly or biweekly treatment with subcutaneous PRO 140, a CCR5 monoclonal antibody.
Journal Infect Dis 2010, 201:1481–1487.
https://link.springer.com/article/10.1007/s11904-010-0068-y


Combinatorial Approaches to the Prevention and Treatmentof HIV-1 Infection
Pirrone V, Thakkar N, Jacobson JM, Wigdahl B, Krebs FC.
Antimicrob Agents Chemother. 2011 May;55(5):1831-42
https://www.ncbi.nlm.nih.gov/pubmed/21343462

Synergistic Inhibition of R5 HIV-1 by Maraviroc and CCR5 Antibody HGS004 in Primary Cells: Implications for Treatment and Prevention
OLGA LATINOVIC,a NHUT LE,a MARVIN REITZ,a RANAJIT PAL,b ANTHONY DEVICO,a JAMES S. FOULKE,a ROBERT R. REDFIELD,a and ALONSO HEREDIAa
AIDS. 2011 Jun 1; 25(9): 1232–1235.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748726/


Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection.
Li L, Tian JH, Yang K, Zhang P, Jia WQ.
Cochrane Database Syst Rev. 2014 Jul 26 7):CD008439.
https://www.ncbi.nlm.nih.gov/pubmed/25063928


PRO 140 Monoclonal Antibody to CCR5 Prevents Acute Xenogeneic Graft-versus-Host Disease in NOD-scid IL-2Rynull Mice.
Bioliogy Blood Marrow Transplant. 2018 Feb;24(2):260-266
Burger DR, Parker Y, Guinta K, Lindner D.
https://www.ncbi.nlm.nih.gov/pubmed/29128556



PRO 140, a monoclonal antibody targeting CCR5, as a long-acting, single-agent maintenance therapy for HIV-1 infection
Dhody K, Pourhassan N, Kazempour K, Green D, Badri S, Mekonnen H, Burger D, Maddon PJ
HIV Clin Trials. 2018 Jun;19(3):85-93
https://www.ncbi.nlm.nih.gov/pubmed/29676212



The return of PRO 140, a CCR5-directed mAb
Thompson MA
Current Opinion HIV AIDS. 2018 Jul;13(4):346-353
https://www.ncbi.nlm.nih.gov/pubmed/29708899


PRO 140 Single-Agent Maintenance Therapy for HIV-1 Infection: A 2-Year Update
Jay Lalezari, Kush Dhody, Ula Kowalczyk, Kazem Kazempour, Nader Pourhassan and Paul J. Maddon
ASM 2018 COMBO Poster
https://content.equisolve.net/_f8eaae214fb1b6...b5fc98.pdf


Primary Efficacy Results of PRO 140 SC in a Pivotal Phase 2b/3 Study in Heavily Treatment-Experienced HIV-1 Patients
ASM 2018 COMBO Poster
Kush Dhody, Kazem Kazempour, Nader Pourhassan and Paul J. Maddon
https://content.equisolve.net/_f8eaae214fb1b6...c8e1bd.pdf


PRO 140 (leronlimab) SC: Long-Acting Single-Agent Maintenance Therapy
CROI 2019 MONO Poster
Kush Dhody, Kazem Kazempour, Nader Pourhassan and Paul J. Maddon
http://www.croiconference.org/sites/default/f...y_0486.pdf


Leronlimab, a humanized monoclonal antibody to CCR5, blocks breast cancer metastasis and enhances cell death induced by DNA damaging chemotherapy
Xuanmao Jiao, Min Wang, Zhiping Li, Richard G. Pestell
AACR 2019
https://s3.amazonaws.com/content.stockpr.com/...%20(1).pdf



Final Results of the Pivotal Study of PRO 140 SC in Heavily Treatment-Experienced HIV Patients
Kush Dhody, Kazem Kazempour, Nader Pourhassan, and Paul J. Maddon
ASM 2019 COMBO Poster
https://content.equisolve.net/_f8eaae214fb1b6..._Final.pdf


Recent Advances Targeting CCR5 for Cancer and Its Role in Immuno-Oncology
Xuanmao Jiao, Omar Nawab, Tejal Patel, Andrew V. Kossenkov, Niels Halama, Dirk Jaeger and Richard G. Pestell
Cancer Research Journal, October 2019 Volume 79, Issue 19
https://cancerres.aacrjournals.org/content/79/19/4801.short



Cytokine CCL5 and receptor CCR5 axis in glioblastoma multiforme
Miha Koprivnikar Kranjc, Metka Novak, Richard G. Pestell, Prof. Tamara T. Lah
The Journal of Association of Radiology and Oncology, Vol 53, Iss 4
https://www.degruyter.com/view/j/raon.2019.53...9-0057.xml

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lululemon Faces Lawsuit Over Alleged Fraudulent Reporting

Updated Category News Views 191

What's Stirring the Pot for Lululemon? Talk about a rollercoaster. Over here, Lululemon (NASDAQ:LULU) is navigating turbulent waters, facing a class action lawsuit for alleged securities fraud. Investors who bought into the brand between March 18, 2026, and September 3, 2026, are now watching their investments drop, following what's claimed as misleading trumpet calls...

Continue Reading
Choosing Lakefront Flooring: A Practical Guide for Owners

Updated Category News Views 87

Understanding Lakefront Challenges Owning a lakefront rental sounds like a dream, right? But the reality involves a mixed bag of conditions that can chew up flooring faster than a pair of puppy claws on exposed oak. We're talking about moisture, sand, and constant guest traffic making these properties a hot mess if you're not careful. Waterproof Vinyl: The Smart Bet...

Continue Reading
Mazda's Winter Sales Event Heats Up Auto Market

Updated Category News Views 83

Winter Discounts? Mazda's Driving It Home Nothing gets a car buyer buzzing like the smell of fresh discounts, and Mazda's rolled out their annual Winter Sales fiesta. We've seen this playbook before, but this year's savings come with up to $3,000 off select models. Mazda's throwing in some sweet financing deals, too—talk about a one-two punch for bargain hunters....

Continue Reading
Gastops and Anschütz: Boosting Canada's Submarine Project

Updated Category News Views 62

New Partnership on the Horizon for Canada’s Submarines In today's world, where defense contracts become the dance of global players, Gastops and Anschütz have clasped hands to join the orchestra. The news blew in from EURONAVAL 2026, where these two powerhouses in condition monitoring and missile systems, respectively, inked a fresh Memorandum of Understanding to back...

Continue Reading
CData Software: A Challenger in Data Integration

Updated Category News Views 89

CData Software Earns Challenger Status Here we are, folks. CData Software just snagged the 'Challenger' title in the 2026 Gartner® Magic Quadrant™ for Data Integration Tools. For the uninitiated, that's a feather in the cap for these data wizards, proving they've got real skin in the game when it comes to connecting the data dots across enterprise landscapes. It’s...

Continue Reading
I-CAR Commends Excellence in Collision Repair Education

Updated Category News Views 253

Spotlighting Integrity and Leadership in Collision Repair You don't often see discussions about car repair lighting up the room, but here we are. At the 2026 SEMA Show in Las Vegas, I-CAR really turned heads by honoring those steadfast pros who've stuck their necks out to ensure the collision repair industry thrives. Justin Lewis and Victor Auto Body Works have been...

Continue Reading
Key Insights on Effective Commercial Property Management

Updated Category News Views 54

Unpacking Commercial Property Management Essentials Dive into the nitty-gritty of what keeps commercial properties ticking like a well-oiled machine, courtesy of Jayna D. Byrnes' expertise. If you're thinking it's all about collecting rent checks, think again. Byrnes, who helms KCM Commercial Property Management, lays out the full spectrum of services that transform a...

Continue Reading
RSPO RT2026 Tackles Indonesian Fires and Export Shifts

Updated Category News Views 42

Indonesia's Burning Questions There's been a lot of smoke—literally and figuratively—hanging over the palm oil industry in Indonesia this year. At the RSPO's Annual Roundtable on Sustainable Palm Oil (RT2026), attendees didn't shy away from addressing the harsh realities. In a year marked by rampant fires, thanks to the blistering El Niño, the RSPO showcased data...

Continue Reading
Natixis' $100M Student Challenge Mixes Real Stakes

Updated Category News Views 127

Opportunity Knocks for Budding Portfolio Managers Picture this: You're a student, neck-deep in textbooks and theories, and then bam! You're handed the keys to manage a $100 million portfolio. That's the real-deal opportunity Natixis Investment Managers is dangling with its seventh Students Challenge. Diving Into the Nuts and Bolts Listen up, kids. Applications are open...

Continue Reading
2027 Shanghai Boat Show: 30 Years of Nautical Ambition

Updated Category News Views 151

The 2027 Shanghai Boat Show: A Decades-Spanning Legacy You ever catch the wave just right, feeling that rush when the tide’s in your favor? That’s the buzz around the 2027 China (Shanghai) International Boat Show—better known as CIBS—celebrating its 30th anniversary. In this boat show shindig, we're looking at a whole host of innovations that could power up this...

Continue Reading

Top 5 Most Recently Viewed Articles

Arts of Imagination Foundation Celebrates Iconic Art Acquisition

Updated Category News Views 353

Iconic Art Acquisition by the Arts of Imagination Foundation The Arts of Imagination Foundation (AOIF) has proudly announced an exceptional addition to its collection: the original cover art for the beloved book Charlotte's Web, created by the talented illustrator Garth Williams. This noteworthy acquisition not only honors a widely cherished children’s classic but also...

Continue Reading
DXC Technology Teams with Ferrari for Advanced Automotive HMI

Updated Category News Views 140

DXC Technology Partners with Ferrari for Next-Gen HMI Development DXC Technology (NYSE: DXC) has entered a groundbreaking partnership with Ferrari aimed at transforming the driver experience through advanced Human Machine Interface (HMI) systems in the latest automotive models. This collaboration allows DXC to leverage its extensive expertise in the automotive sector to...

Continue Reading
Innovations in Fleet Management: What to Expect at 2025 Event

Updated Category News Views 187

Innovations in Fleet Management: What to Expect at 2025 Event Gurtam has exciting plans for its flagship event, Telematics & Connected Mobility 2025, which aims to dive deeply into the advancements in fleet management and connected mobility technology. This event is set to take place on the 10th and 11th of September 2025, where industry enthusiasts will gather to explore...

Continue Reading
Innovative Partnership to Revolutionize Osteoporosis Detection

Updated Category News Views 44

Strategic Alliance to Enhance Osteoporosis Awareness Naitive Technologies Ltd., a leader in population health innovation focused on musculoskeletal care, has embarked on an important partnership with Parvizi Surgical Innovation (PSI). This collaboration aims to significantly improve the detection and clinical management of osteoporosis, particularly through the use of...

Continue Reading
Intercontinental Exchange Expands Reach with AFX Acquisition

Updated Category News Views 219

Intercontinental Exchange's Strategic Acquisition of AFX Intercontinental Exchange, Inc. (NYSE: ICE), a renowned leader in technology and data services, has made headlines by acquiring the American Financial Exchange (AFX). This electronic platform focuses on lending and borrowing among American banks and financial institutions, positioning ICE to strengthen its influence...

Continue Reading